|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT2016120330347N1 |
|
Date of registration:
|
2016-12-03 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Comparing the effect of Ranitidin and Pantoprazole on Mg level
|
|
Scientific title:
|
Comparing the effect of Ranitidin and Pantoprazole on PICU patients in Imam hossein hospital |
|
Date of first enrolment:
|
2016-08-17 |
|
Target sample size:
|
70 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/24139 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Elahe Mansouri
|
|
Address:
|
Isfahn University of Medical Sciences,Hezargarib street, Isfehan
Isfehan
Iran (Islamic Republic of) |
|
Telephone:
|
+98 31 3450 1914 |
|
Email:
|
Kosar.mansouri@gmail.com |
|
Affiliation:
|
Isfahn University of Medical Sciences |
|
|
Name:
|
Dr. Mohammad Reza Habibzade
|
|
Address:
|
Isfahn University of Medical Sciences, Imam khomeini street, lmam hossein hospital
Isfehan
Iran (Islamic Republic of) |
|
Telephone:
|
+98 31 3450 1914 |
|
Email:
|
habibzadeh@med.mui.ac.ir |
|
Affiliation:
|
Isfahn University of Medical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion: age from 2 months to 15 years old children admited in PICU; consent to participate in the study.
Exclusion criteria: discharging before the end of the study; any condition that need to change the dose of Ranitidin or Pantoprazole for patients e.g GI bleeding.
Exclusion criteria:
Age minimum:
2 months
Age maximum:
15 years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Magnesium deficiency.
|
|
Intervention(s)
|
|
Ranitidin, IV, 1 mg/ kg, BID, till end of the study
|
|
Pantoprazol, IV, BID,1 mg / kg, till end of the study
|
|
Intervention 1: Ranitidin, IV, 1 mg/ kg, BID, till end of the study. Intervention 2: Pantoprazol, IV, BID,1 mg / kg, till end of the study.
|
|
Treatment - Drugs
|
|
Primary Outcome(s)
|
|
Magnesium level. Timepoint: Daily since 7 days. Method of measurement: Labratory kit.
|
|
Source(s) of Monetary Support
|
|
Isfahn University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Isfahn University of Medical Sciences
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|